UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (9239) 9239
Journal Article (7898) 7898
Newsletter (1373) 1373
Web Resource (113) 113
Magazine Article (67) 67
Book Review (38) 38
Book Chapter (35) 35
Trade Publication Article (25) 25
Report (12) 12
Transcript (5) 5
Book / eBook (4) 4
Conference Proceeding (2) 2
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
coronaviruses (14256) 14256
severe acute respiratory syndrome coronavirus 2 (13840) 13840
covid-19 (13298) 13298
science & technology (6090) 6090
humans (5659) 5659
pandemics (5169) 5169
life sciences & biomedicine (4885) 4885
severe acute respiratory syndrome (4793) 4793
immunology (4229) 4229
infections (4100) 4100
vaccines (4015) 4015
medical research (3772) 3772
viruses (3645) 3645
antibodies (3272) 3272
sars-cov-2 (2900) 2900
infectious diseases (2664) 2664
health aspects (2656) 2656
disease transmission (2390) 2390
female (2187) 2187
male (2077) 2077
proteins (2023) 2023
clinical trials (1914) 1914
viral diseases (1896) 1896
patients (1788) 1788
research (1634) 1634
stockholders (1610) 1610
animals (1567) 1567
adult (1468) 1468
epidemics (1467) 1467
middle aged (1455) 1455
earnings per share (1450) 1450
public health (1410) 1410
laboratories (1409) 1409
researchers (1395) 1395
immune system (1392) 1392
mortality (1333) 1333
medicine (1243) 1243
viral infections (1195) 1195
science & technology - other topics (1179) 1179
multidisciplinary sciences (1161) 1161
respiratory diseases (1144) 1144
cytokines (1142) 1142
hospitals (1096) 1096
archives & records (1086) 1086
aged (1077) 1077
virology (1063) 1063
inflammation (1038) 1038
influenza (975) 975
epidemiology (965) 965
antigens (961) 961
medicine, experimental (954) 954
lymphocytes (950) 950
disease (915) 915
biotechnology industry (871) 871
coronavirus infections - epidemiology (857) 857
pneumonia (857) 857
microbiology (849) 849
analysis (830) 830
net losses (825) 825
betacoronavirus (800) 800
pneumonia, viral - epidemiology (791) 791
coronavirus infections - virology (790) 790
collaboration (769) 769
coronavirus infections - immunology (768) 768
risk factors (761) 761
pneumonia, viral - virology (709) 709
immune response (687) 687
pneumonia, viral - immunology (684) 684
pharmaceutical industry (669) 669
covid-19 diagnostic tests (657) 657
coronavirus (651) 651
genomes (643) 643
sars virus - immunology (641) 641
severe acute respiratory syndrome - immunology (612) 612
pathogens (609) 609
antibodies, viral - blood (602) 602
research & development--r&d (600) 600
drug dosages (586) 586
pathogenesis (584) 584
fda approval (581) 581
pediatrics (579) 579
asymptomatic (573) 573
mutation (572) 572
adolescent (561) 561
medicine and health sciences (560) 560
betacoronavirus - immunology (557) 557
gene expression (548) 548
immunotherapy (545) 545
severe acute respiratory syndrome - virology (541) 541
coronavirus infections - diagnosis (536) 536
immunoglobulins (536) 536
review (518) 518
medicine, research & experimental (509) 509
research & experimental medicine (509) 509
abridged index medicus (506) 506
cancer (506) 506
biology and life sciences (497) 497
biological and medical sciences (494) 494
hospitalization (493) 493
health care (489) 489
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18683) 18683
Chinese (134) 134
German (24) 24
Spanish (21) 21
Japanese (12) 12
French (11) 11
Portuguese (7) 7
Russian (5) 5
Turkish (4) 4
Norwegian (2) 2
Hebrew (1) 1
Hungarian (1) 1
Latvian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Emerging infectious diseases, ISSN 1080-6040, 07/2020, Volume 26, Issue 7, pp. 1478 - 1488
Journal Article
Leukemia, ISSN 0887-6924, 07/2020, Volume 34, Issue 7, pp. 1726 - 1729
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Betacoronavirus - pathogenicity | Severe Acute Respiratory Syndrome - epidemiology | Coronavirus Infections - drug therapy | Furans - pharmacology | Humans | Pneumonia, Viral - drug therapy | Severe Acute Respiratory Syndrome - immunology | T-Lymphocytes - virology | Betacoronavirus - immunology | COVID-19 | SARS-CoV-2 | Inflammasomes - antagonists & inhibitors | Myocarditis - epidemiology | T-Lymphocytes - drug effects | Myocarditis - prevention & control | Acute Kidney Injury - immunology | Hematopoietic Stem Cells - virology | Cytokines - genetics | Sulfones | Spike Glycoprotein, Coronavirus - genetics | Risk Factors | NLR Family, Pyrin Domain-Containing 3 Protein - antagonists & inhibitors | Sulfonamides - pharmacology | Coronavirus Infections - immunology | Pyroptosis - genetics | Angiotensin-Converting Enzyme 2 | Coronavirus Infections - virology | T-Lymphocytes - immunology | Immunologic Factors - pharmacology | Pandemics | Pyroptosis - drug effects | Severe Acute Respiratory Syndrome - virology | Heterocyclic Compounds, 4 or More Rings | NLR Family, Pyrin Domain-Containing 3 Protein - genetics | Peptidyl-Dipeptidase A - genetics | Acute Kidney Injury - virology | Hematopoietic Stem Cells - immunology | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Spike Glycoprotein, Coronavirus - immunology | Myocarditis - immunology | Cytokines - immunology | Hematopoietic Stem Cells - drug effects | Cytokine Release Syndrome - immunology | Cytokine Release Syndrome - virology | Immunity, Innate - drug effects | Cytokine Release Syndrome - prevention & control | Betacoronavirus - drug effects | Gene Expression Regulation | Cytokine Release Syndrome - epidemiology | Pneumonia, Viral - immunology | Acute Kidney Injury - prevention & control | Inflammasomes - genetics | Myocarditis - virology | Severe Acute Respiratory Syndrome - prevention & control | NLR Family, Pyrin Domain-Containing 3 Protein - immunology | Inflammasomes - immunology | Acute Kidney Injury - epidemiology | Cytokines - antagonists & inhibitors | Peptidyl-Dipeptidase A - immunology | Pneumonia, Viral - virology | Pyroptosis - immunology | Medical colleges | Cytokines | Health aspects | Hematopoietic stem cells | Severe acute respiratory syndrome | Viral diseases | Storm damage | Viruses | Risk analysis | Progenitor cells | Cytokine storm | Risk factors | Hemopoiesis | Severe acute respiratory syndrome coronavirus 2 | Myocarditis | Stem cells | Heart diseases | Index Medicus
Journal Article
JCI insight, ISSN 2379-3708, 02/2019, Volume 4, Issue 4
Journal Article
by Carvelli, Julien and Demaria, Olivier and Vély, Frédéric and Batista, Luciana and Chouaki Benmansour, Nassima and Fares, Joanna and Carpentier, Sabrina and Thibult, Marie-Laure and Morel, Ariane and Remark, Romain and André, Pascale and Represa, Agnès and Piperoglou, Christelle and Assante  Miranda, Laura and Baron, William and Belaid, Nourhène and Caillet, Clarisse and Caraguel, Flavien and Carrette, Barbara and Carrette, Florent and Chanuc, Fabien and Courtois, Rachel and Fenis, Aurore and Giordano, Marilyn and Girard-Madoux, Mathilde and Giraudon-Paoli, Marc and Gourdin, Nicolas and Grondin, Gwendoline and Guillot, Franceline and Habif, Guillaume and Jaubert, Solène and Lopez, Julie and Le Van, Mélanie and Lovera, Naouel and Mansuy, Marine and Bonnet, Elodie and Sansaloni, Audrey and Reboul, Annick and Mitry, Emmanuel and Nekkar-Constant, Camille and Péri, Valentine and Ricaut, Paul and Simon, Léa and Vallier, Jean-Baptiste and Vétizou, Marie and Zerbib, Robert and Ugolini, Sophie and Etiennot, Marion and Galluso, Justine and Lyonnet, Luc and Forel, Jean-Marie and Papazian, Laurent and Velly, Lionel and André, Baptiste and Briantais, Antoine and Faucher, Benoit and Jean, Estelle and Seguier, Julie and Veit, Veronique and Harlé, Jean-Robert and Pastorino, Boris and Delteil, Clémence and Daniel, Laurent and Boudsocq, Jean-Paul and Clerc, Axelle and Delmond, Emmanuel and Vidal, Pierre-Olivier and Savini, Hélène and Coutard, Bruno and Cordier, Pierre Yves and Le Dault, Erwan and Guervilly, Christophe and Simeone, Pierre and Gainnier, Marc and Morel, Yannis and Ebbo, Mikael and Schleinitz, Nicolas and Vivier, Eric and Explore COVID-19 Marseille Immunop and Explore COVID-19 IPH Grp and Explore COVID-19 Marseille Immunopole group and Explore COVID-19 IPH group and the Explore COVID-19 IPH group and the Explore COVID-19 Marseille Immunopole group
Nature (London), ISSN 0028-0836, 12/2020, Volume 588, Issue 7836, pp. 146 - 150
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | COVID-19 - immunology | Inflammation - pathology | Humans | Bronchoalveolar Lavage Fluid - immunology | Respiratory Distress Syndrome - immunology | Complement C5a - biosynthesis | Inflammation - complications | Respiratory Distress Syndrome - prevention & control | Acute Lung Injury - prevention & control | COVID-19 - complications | Inflammation - drug therapy | Myeloid Cells - immunology | COVID-19 - blood | Receptor, Anaphylatoxin C5a - immunology | SARS-CoV-2 - drug effects | Female | Myeloid Cells - drug effects | Respiratory Distress Syndrome - drug therapy | SARS-CoV-2 - immunology | Acute Lung Injury - drug therapy | Cytokine Release Syndrome - drug therapy | Disease Models, Animal | Cytokine Release Syndrome - immunology | Lung - pathology | CD11b Antigen - immunology | Cytokine Release Syndrome - prevention & control | Mice, Inbred C57BL | Inflammation - immunology | Complement C5a - antagonists & inhibitors | Animals | SARS-CoV-2 - pathogenicity | Receptor, Anaphylatoxin C5a - blood | Lung - drug effects | COVID-19 - pathology | Acute Lung Injury - immunology | Mice | Bronchoalveolar Lavage Fluid - chemistry | CD11b Antigen - metabolism | Complement C5a - immunology | Myeloid Cells - pathology | Receptor, Anaphylatoxin C5a - antagonists & inhibitors | Lung - immunology | Myeloid cells | Immune response | Complement component C5a | Severe acute respiratory syndrome | Viral diseases | Organs | Bronchus | Leukocytes (neutrophilic) | Inflammation | Coronaviruses | Blood | Recruitment | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Smoke inhalation | Receptors | Cell activation | Respiratory distress syndrome | Lungs | Bronchoalveolar lavage | Respiratory diseases | Monoclonal antibodies | Alveoli | Immune system | Index Medicus
Journal Article
Journal Article